Xuanzhu Biopharmaceutical Co., Ltd. logo

Xuanzhu Biopharmaceutical Co., Ltd. (2575)

Market Open
7 Aug, 08:00
HKEX HKEX
12. 48
HKD
+0.39
+3.2258%
HKD
32.63B Market Cap
- P/E Ratio
- Div Yield
399,489 Volume
- Eps
12.09 HKD
Previous Close
Add Transaction
Day Range
11.88 12.65
Year Range
10.6 96.9
Want to track 2575 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Xuanzhu Biopharmaceutical Co., Ltd. (2575) Statistics

Valuation metrics

Market Cap 32.63B
Enterprise value 5.7B
Trailing P/E (ttm) -24.47
Forward P/E -
PEG ratio -0.24
Price/Sales (ttm) 115.12
Price/Book (mrq) 4.24
Enterprise Value/Revenue 101.5
Enterprise Value/EBITDA -25.84

Overview

Shares outstanding 517.95M
Float 142.8M
Shares short -
% Held by insiders 0.85%
% Held by institutions 0.01%
Average volume (10 days) 477.12K
Average volume (90 days) 1.6M

Price summary

52-Week low 10.6
52-Week high 96.9
Beta -
50-Day moving average 12.92
200-Day moving average 32.25

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -4.74%
Operating margin -4.51%

Operational effectiveness

Return on assets -0.15%
Return on equity -0.21%

Income Statement

Revenue (ttm) 59.93M
Revenue per share (ttm) 0.11
Quarterly revenue growth (yoy) 1.41%
Gross profit (ttm) 29.77M
EBITDA -238.05M
Net income to common (ttm) -284.21M
Diluted EPS (ttm) -0.51
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 755.09M
Total cash per share (mrq) 1.48
Total debt (mrq) 748.99K
Total Debt/Equity (mrq) 0
Current ratio (mrq) 3.75%
Book value per share (mrq) 2.95

Cash Flow

Cash flow statement -243.06M
Levered free cash flow (LFCF) -197.58M